Assessment of Puberty in Relation to L-carnitine and Hormonal Replacement Therapy in -thalassemic Patients
Open Access
- 1 May 2008
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Tropical Pediatrics
- Vol. 54 (6) , 375-381
Abstract
Objective: To investigate puberty in a group of thalassemic patients with delayed or arrested pubertal development and to compare the effects of hormonal and l-carnitine therapy on puberty in those patients.Keywords
This publication has 17 references indexed in Scilit:
- β-ThalassemiaNew England Journal of Medicine, 2005
- Cardiovascular effects of splenomegaly and splenectomy in β-thalassemiaAnnals of Hematology, 2005
- Endocrine Gland Abnormalities in Thalassemia Major: Λ Brief ReviewJournal of Pediatric Endocrinology and Metabolism, 2003
- Multicentre study on prevalence of endocrine complications in thalassaemia majorClinical Endocrinology, 1995
- The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approachesClinical Endocrinology, 1995
- Thyroid disorders and diabetes mellitus as complications of thalassaemia majorActa Paediatrica, 1994
- Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major.Archives of Disease in Childhood, 1994
- Potential of Gonadotropin-Releasing Hormone Agonists in the Diagnosis of Pubertal Disorders in GirlsClinical Obstetrics and Gynecology, 1993
- Multiple hormone deficiencies in children with hemochromatosisThe Journal of Clinical Endocrinology & Metabolism, 1993
- Effect of Age at the Start of Iron Chelation Therapy on Gonadal Function in β-Thalassemia MajorNew England Journal of Medicine, 1990